Latest biotech News

Lumos Diagnostics secures authorisation for test in Canada
Starpharma signs expanded DEP research agreemnent with Genentech
Investment funds support university commercialisation
Victorian government to grant to Hudson Institute for collaboration with Noxopharm
Volpara Health in new collaboration with Microsoft
NSW & QLD Government investments into industry welcomed
New orphan drug designation for Kazia Therapeutics’ paxalisib
Life sciences industry says IP waiver an ’empty shell’ and fact-free decision
High appetite for biotech VC cited in new report
Major software acquisition for leading Australian company ResMed
Registrations are open to ‘come alive’ at AusBiotech 2022
NeuroScientific Biopharmaceuticals reports positive data from animal study
Telix and RefleXion expand partnership for prostate cancer treatment
Regeneus chief executive makes off-market investment in company
Significant growth symbolic of biotech sector’s sovereign value
Dimerix enters agreement for new trial of DMX-200 in diabetic kidney disease
Clarity secures US IND approval for phase 2 prostate cancer trial
Immutep reports positive overall response rate in lung cancer trial
First patient recruited in Dimerix late-stage trial
New appointment to Imugene’s scientific advisory board
One-stop shop for clinical trials enters its second phase
Adherium provides update on senior management
Cynata Therapeutics adds new site for MEND clinical trial
Profile successes and add your voice
Archer Materials secures Australian patent for quantum computing chip
New clinical trial to test cancer drug in motor neuron disease
Thriving medtech community celebrated at record-breaking AusMedtech 2022
AusBiotech welcomes incoming Federal Government
Twenty-five receive awards recognizing inclusive excellence
AnteoTech’s updated Covid RAT receives regulatory approval in Europe
FDA confirms diagnostic method for Medibio’s final depression validation trial
Illumina’s Susan Tousi on genomics and changing healthcare
Nyrada says European patent to be granted for cholesterol-lowering drug
PharmAust says MPL tablets arrive for Motor Neuron Disease trial
Help AusBiotech 2022 programme ‘Come Alive’
Immuron partner submits IND application to US FDA for new therapeutic
NeuroScientific Biopharmaceuticals submits for approval of early-phase trial
Industry-backed plan to navigate Australian biotech into future
CSL Welcomes US Court Ruling
Prescient expands PTX-200 AML cohort following additional complete remission
NSW Government launches 20-year roadmap for industry
New senior appointments for Tessara Therapeutics
Botanix acquires rights to new dermatology product
Biotron says BIT225 against SARS-CoV-2 infection effective in animals
INOViQ announces manufacturing agreement with MP Biomedicals
Cochlear agrees to acquire Oticon Medical
First subjects randomised and dosed in Paradigm’s late-stage trial
Adherium releases next generation respiratory platform integration services